Clinical Trials Browser

Injections × Plasma cell × 90 days × Clear all

NCT06574568 2026-02-05

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma, Recurrence

NCT05020236 2026-02-02

MAGNETISMM-5

Phase 3 Recruiting

Multiple Myeloma